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Cell fate depends on Golgi
T
he Golgi hides the partner of a stem-cell fate protein, according to 
results from Yan Zhou, Weimin Zhong (Yale University, New Haven, 
CT), and colleagues. Only when its partner is briefl  y freed during 
Golgi disassembly can Numb defend the undifferentiated state.
Numb has a paradoxical role in cell fate: 
when a neuronal progenitor divides, Numb 
keeps one daughter in the progenitor state 
by inhibiting Notch. Yet Numb is also needed 
for neuronal differentiation. To solve this 
mystery, Zhong’s group fi  shed for Numb’s 
binding partners. They found a Golgi protein 
called ACBD3 whose brief cytosolic 
appearances during mitosis turned Numb 
into a supporter of the progenitor fate.
During progenitor division, Numb is 
sent to one daughter, where it carries on 
the progenitor fate. The authors found that 
Numb’s binding to ACBD3 was required 
for this progenitor maintenance. This 
binding was only possible during mitosis, 
when the Golgi disassembled and ACBD3 
was released into the cytosol to meet 
Numb. Given this narrow window of 
opportunity, Zhong fi  gures, “fate must be determined before cells are even 
fi  nished dividing. After that, it might be just maintenance.”
The lack of Numb in the other daughter allowed for Notch-orchestrated 
neuronal differentiation. But later, this neuron’s survival depended on newly 
made Numb and its ACBD3-free activity. Forcing ACBD3 to remain in the 
cytosol inhibited neurogenesis.
Other stem cells probably also depend on Numb and the Golgi-organized 
timing of ACBD3 release. And there’s no reason to assume that ACBD3 is the 
only protein that exploits Golgi dynamics. “Golgi fragmentation in lots of verte-
brate cells may be doing more than divvying up the organelle,” says Zhong.
Reference: Zhou, Y., et al. 2007. Cell. 129:163-178.
Glycan growth 
switch
T
hose sugary glycan moieties that adorn 
cell surface receptors are more than deco-
ration. Their ability to prevent receptor en-
docytosis is well established. Now, Ken Lau, 
James Dennis (University of Toronto, Canada), 
and colleagues show that differences in receptors’ 
glycan decorations time a cell’s transition from 
growth to arrest.
Receptors that promote growth generally 
have more sites for glycan addition than do recep-
tors that halt growth and start differentiation. The 
authors found that these receptor groups respond-
ed differently to changes in metabolite status, 
which determines the complexity of the added gly-
cans (more sugar-nucleotides means more intricate-
ly branched glycans are created in the Golgi).
With their many glycans, growth receptors 
were cross-linked by sugar-binding galectins and 
retained on the surface even in stringent growth 
conditions. Receptors that promote differentiation 
required higher sugar-nucleotide levels before 
their fewer glycans gained enough galectin-bind-
ing branches to counter their loss by endocytosis.
The upshot, says Dennis, is “a principle of 
how cells regulate the ratio of growth and arrest 
receptors in a cell-autonomous manner 
downstream of nutrients. First, an increase in 
proliferation is accompanied by glucose uptake 
and increased metabolism.” Then when metabolite 
ﬂ  ux  sufﬁ   ciently increases sugar-nucleotides and 
the branched glycans, differentiation receptors 
can accumulate, turning off proliferation.
Reference: Lau, K.S., et al. 2007. Cell. 129:123-134.
Immunity raises cholesterol
O
ur immune system is trying to give us a heart attack. Findings from James Lo, Yugang Wang, 
Godfrey Getz, Yang-Xin Fu (University of Chicago, IL), and colleagues reveal that T cells hinder 
the liver’s ability to remove cholesterol from the blood.
The immune system and the liver were previously linked by a mouse model of infl  ammation that causes 
the animals to have enlarged livers. These mice express high levels of proinfl  ammatory molecules called 
LIGHT and LT on their T cells. The authors now fi  nd that LIGHT-expressing T cells bump up triglyceride and 
cholesterol levels in the mouse bloodstream.
These lipids are normally broken down by the liver. But T cells carrying LIGHT caused 
liver cells to make less hepatic lipase, which hydrolyzes triglycerides and phospholipids. 
Interfering with LIGHT’s ability to bind to its LTβR receptor on liver cells lowered 
cholesterol levels, even in mice that did not have high LIGHT levels to begin with.
High cholesterol is also caused by genetic diseases linked to the loss of the low-density 
lipoprotein receptor. The group found that mice lacking this receptor also benefi  t from the 
blockade of LIGHT signaling. A practical means to thwart LIGHT in humans has not yet 
been devised. Whether the high risk of heart disease associated with autoimmune diseases is 
also caused by LIGHT remains to be seen.
Reference: Lo, J.C., et al. 2007. Science. 316:285-288.
Escape of ACBD3 (green) from 
fragmented Golgi (red) allows it 
to bind Numb during mitosis.
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Mice with LIGHT-expressing T cells (right 
bar) have high cholesterol.